Glypican-3-specific antibody and uses thereof
AssigneesThe Trustees of the University of Pennsylvania, The United States of America as represented by the Secretary of the Department of Veterans Affairs
InventorDavid Kaplan
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions and methods for diagnosing and treating diseases, disorders or conditions associated with dysregulated expression of GPC3. The invention provides novel antibodies that specifically bind to glypican-3 (GPC3). The invention also relates to a fully human chimeric antigen receptor (CAR) wherein the CAR is able to target GPC3.
Claims4
An isolated and substantially purified polynucleotide encoding a single chain human anti-glypican-3 (GPC3) antibody fragment, wherein the single chain antibody fragment comprises a heavy chain variable region and light chain variable region, wherein the amino acid sequence of the heavy chain variable region and the amino acid sequence of the light chain variable region are selected from the group consisting of:
- (a) SEQ ID NO:
- 12 and SEQ ID NO:
- 17;
- (b) SEQ ID NO:
- 13 and SEQ ID NO:
- 18;
- (c) SEQ ID NO:
- 14 and SEQ ID NO:
- 19;
- and, (d) SEQ ID NO:
- 15 and SEQ ID NO:
- 20.
Dependencies are inferred from the claim text.